多西环素暴露后预防对意大利米兰淋球菌耐药的影响
这项回顾性队列研究纳入2022年1月至2025年6月米兰San Raffaele医院318例培养确诊淋球菌感染者共376次发作,评估多西环素暴露后预防(DoxyPEP)与淋球菌表型耐药及MIC的关联。结果显示DoxyPEP暴露与高水平四环素耐药及头孢曲松敏感性下降相关,但校正多重比较后仅头孢曲松敏感性下降的关联仍显著,未见头孢曲松耐药株或整体MIC漂移。
要点
- DoxyPEP暴露与高水平四环素耐药相关(校正OR 1.87,95%CI 1.01-3.47)。
- DoxyPEP暴露与头孢曲松敏感性下降相关(校正OR 7.34,95%CI 1.69-31.90)。
- 校正多重比较后仅头孢曲松敏感性下降关联显著,未见头孢曲松耐药株。
核心结论
- 在淋球菌四环素耐药近乎普遍的环境中,DoxyPEP对高水平四环素耐药的筛选作用有限。
- 观察到DoxyPEP与罕见头孢曲松敏感性下降病例的可能关联,但无更广泛MIC漂移或头孢曲松耐药证据。
研究设计与样本
- 回顾性队列研究,纳入2022年1月1日至2025年6月30日San Raffaele医院培养确诊淋球菌感染者。
- 共318人、376次淋球菌发作;中位年龄34.8岁(IQR 30.0-39.8),373/376(99.2%)为男性。
- DoxyPEP自2022年8月起提供,自我报告使用后的发作归类为暴露组,共77/376次(20.5%)。
- 采用梯度条法测定MIC,按EUCAST 15.0标准判读;使用广义估计方程逻辑回归分析关联,稀疏结局采用Firth校正。
主要发现
- 总体耐药频繁:四环素360/375(96.0%),高水平四环素耐药64/375(17.1%),环丙沙星250/342(73.1%),阿奇霉素36/360(10.0%),苄青霉素40/340(11.8%)。
- β-内酰胺酶阳性58/335(17.3%);头孢曲松敏感性下降8/375(2.1%),无头孢曲松耐药分离株。
- DoxyPEP暴露与高水平四环素耐药相关:暴露组19/77(25.0%)vs 非暴露组45/298(15.1%),校正OR 1.87(95%CI 1.01-3.47,p 0.045)。
- DoxyPEP暴露与头孢曲松敏感性下降相关:暴露组5/77(6.5%)vs 非暴露组3/298(1.0%),校正OR 7.34(95%CI 1.69-31.90,p 0.008)。
- 校正多重比较后仅头孢曲松敏感性下降关联仍显著;暴露组与非暴露组校正几何平均MIC重叠。
关键数值与推荐
- 高水平四环素耐药定义为MIC > 8 mg/L。
- 头孢曲松敏感性下降定义为MIC > 0.032 mg/L(流行病学折点)。
- MIC判读采用EUCAST标准版本15.0。
临床怎么用
- 在淋球菌四环素耐药高流行地区,DoxyPEP对高水平四环素耐药的额外选择压力有限。
- 实施DoxyPEP时应监测淋球菌头孢曲松敏感性,尤其关注罕见敏感性下降病例。
局限性
- 回顾性单中心设计,DoxyPEP暴露基于自我报告。
- 头孢曲松敏感性下降结局稀疏,关联估计精度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Doxycycline post-exposure prophylaxis (DoxyPEP) reduces bacterial sexually transmitted infections, but it selects for tetracycline-resistant gonorrhoea and might co-select for ceftriaxone resistance. The aim of this study was to assess DoxyPEP association with gonorrhoea phenotypic antimicrobial resistance and MICs in a real-world setting. METHODS: This was a retrospective cohort study of people with culture-confirmed gonorrhoea at San Raffaele Hospital (1 January 2022-30 June 2025). DoxyPEP was offered from August 2022; episodes after self-reported DoxyPEP use were classified as exposed. MICs for ceftriaxone, ciprofloxacin, tetracycline, azithromycin, and benzylpenicillin were measured by gradient strips and interpreted with European Committee on Antimicrobial Susceptibility Testing criteria version 15.0. High-level tetracycline resistance was MIC > 8 mg/L; decreased ceftriaxone susceptibility was MIC > 0.032 mg/L (epidemiological cut-off). Associations with resistance outcomes were estimated using generalized estimating equation logistic regression, with Firth correction applied for sparse outcomes; log-MIC generalized estimating equation models compared adjusted geometric mean MICs (adjusted for age, HIV status, pre-exposure prophylaxis use, and prior bacterial sexually transmitted infections). RESULTS: A total of 318 individuals with 376 gonorrhoea episodes (373 of 376 (99.2%) in men) were included (median age 34.8 years, interquartile range 30.0-39.8); 217 of 376 (57.7%) occurred during pre-exposure prophylaxis, and 76 of 376 (20.2%) were among people with HIV. Seventy-seven of 376 episodes (20.5%) were DoxyPEP-exposed. Overall, resistance was frequent: tetracycline 360 of 375 (96.0%), high-level tetracycline resistance 64 of 375 (17.1%), ciprofloxacin 250 of 342 (73.1%), azithromycin 36 of 360 (10.0%), and benzylpenicillin 40 of 340 (11.8%); β-lactamase positivity was 17.3% (58 of 335). Decreased ceftriaxone susceptibility occurred in 2.1% (8 of 375), with no ceftriaxone-resistant isolates. In adjusted models, DoxyPEP exposure was associated with high-level tetracycline resistance (19 of 77 (25.0%) vs. 45 of 298 (15.1%); adjusted OR 1.87; 95% CI, 1.01-3.47; p 0.045) and decreased ceftriaxone susceptibility (5 of 77 (6.5%) vs. 3 of 298 (1.0%); adjusted OR = 7.34; 95% CI, 1.69-31.90; p 0.008). After correction for multiple comparisons, only the association with decreased ceftriaxone susceptibility remained significant. Adjusted geometric mean MICs overlapped between exposed and unexposed episodes. CONCLUSIONS: In this setting of near-universal gonococcal tetracycline resistance, the contribution of DoxyPEP in selecting high-level tetracycline resistance was limited. Possible association with rare cases of decreased ceftriaxone susceptibility was observed, without evidence of broader MIC shifts or ceftriaxone resistance.
引用
- Raccagni AR, Sagramoso C, Capra N, et al. Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy. Clin Microbiol Infect. 2026. PMID: 42217672. doi:10.1016/j.cmi.2026.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。